Tricuspid Regurgitation: When to Repair and When to Replace

Rahul R. Handa, MD
October 7, 2025
#blog
Medical illustration of cardiac surgery showing atrial myxoma tumor removal from heart chamber with surgical retractors and superior vena cava (SVC) labeled, demonstrating open heart surgical technique for cardiac tumor excision

Introduction

Tricuspid regurgitation (TR) occurs when the tricuspid valve fails to close properly, allowing blood to flow backward from the right ventricle into the right atrium. Although often overlooked, severe TR can lead to right-sided heart failure, liver congestion, and fluid retention. Understanding when surgical repair versus replacement is optimal empowers patients and families to make informed decisions.

Understanding Tricuspid Regurgitation

Etiology and Classification

TR may be primary (structural valve disease) or secondary (dilation of the right ventricle / annulus). Common causes include:

  • Secondary TR due to left-sided heart disease or pulmonary hypertension
  • Primary TR from endocarditis, rheumatic disease, or congenital abnormalities

Severity is graded by echocardiography as mild, moderate, or severe based on regurgitant volume and vena contracta width.

Clinical Presentation

Symptoms often develop insidiously and include:

  • Fatigue and weakness
  • Abdominal bloating and swelling
  • Jugular venous distension
  • Hepatomegaly and ascites

When to Repair the Tricuspid Valve

Indications for Repair

Repair is preferred when the valve leaflets and subvalvular apparatus are intact, and annular dilation is the primary issue. Consider repair in:

  • Severe functional TR at time of left-sided surgery
  • Moderate TR with annular diameter ≥40 mm
  • Symptomatic patients without advanced right ventricular dysfunction

Repair Techniques

  • Annuloplasty ring implantation to restore annular geometry
  • Leaflet plication or edge-to-edge repair for localized leaflet prolapse

When Replacement Is Necessary

Indications for Replacement

Valve replacement is indicated when:

  • Primary leaflet pathology (e.g., endocarditis, carcinoid)
  • Repair failure or severe tethering of leaflets
  • Recurrent TR after prior repair

Prosthetic Valve Options

  • Bioprosthetic valves offer low thrombosis risk but limited durability
  • Mechanical valves provide longevity but require lifelong anticoagulation

Peri-Operative and Post-Operative Considerations

Sternal Precautions

  • Avoid lifting >10 lbs for 6-8 weeks
  • Support chest when coughing or sneezing

Driving and Flying

  • Resume driving after 4-6 weeks, once sternal stability is confirmed
  • Flying is safe after sternal healing and stable anticoagulation

Plating vs. Wiring

  • Sternal plating may improve comfort in high-risk patients
  • Standard wiring remains effective for most cases

Recovery Timeline

WEEK
1-2

Hospital & Early Home Recovery

Focus on rest, wound healing, and establishing baseline medications. Hospital stay typically 5-7 days for open surgery.

Medical Management:
  • Start anticoagulation (Warfarin/INR monitoring)
  • Diuretic adjustment for fluid balance
  • Baseline echo before discharge
  • Daily wound inspection
Short walks Rest frequently INR checks 2-3x/week
WEEK
3-4

Increasing Activity & Stabilization

Energy improves as right heart function stabilizes. Walking distance extends. Continue sternal precautions strictly.

Monitoring Focus:
  • INR 2.0-3.0 target (bioprosthetic) or 2.5-3.5 (mechanical)
  • Weekly INR once stable
  • Watch for signs of atrial fibrillation
  • Monitor edema/weight daily
Walk 10-15 min Light one-arm tasks Weekly INR No lifting >5 lbs
WEEK
5-6

Expanding Independence

Return to desk work possible. Driving may resume with surgeon clearance. Sternal healing progressing well.

Key Appointments:
  • 6-week post-op cardiology visit
  • Repeat echocardiogram to assess valve function
  • INR monitoring every 2-4 weeks if stable
  • EKG to check for arrhythmias
Driving cleared Return to work Walk 20-30 min Echo follow-up
WEEK
7-8

Sternal Healing Complete

Sternum healed. Most restrictions lift with surgeon approval. Right ventricular function improving.

Treatment Decisions:
  • Bioprosthetic: Continue warfarin until 3-month mark
  • Mechanical: Continue warfarin indefinitely
  • Cardiac rehab enrollment recommended
  • Adjust diuretics as edema resolves
Most limits lift Light exercise OK Normal daily tasks Monthly INR
MONTH
3

3-Month Milestone

Critical reassessment period. Valve function evaluation and anticoagulation decisions finalized.

Major Assessment:
  • Comprehensive echocardiogram
  • Bioprosthetic repair: May stop warfarin, continue aspirin 81mg
  • Mechanical: Continue warfarin lifelong
  • Evaluate for persistent AF (may need anticoagulation)
Full activities Exercise program 3-month echo Anticoag review
MONTH
6-12

Long-Term Recovery & Monitoring

Near-normal function. Establishing lifelong surveillance routine for valve durability and right heart function.

Ongoing Care:
  • 6-month and annual echocardiograms
  • Cardiology visits every 6-12 months
  • INR monitoring per protocol (if anticoagulated)
  • Annual EKG for arrhythmia screening
  • Maintain heart-healthy lifestyle
Full activities All exercise cleared Annual echo Lifelong follow-up

Conclusion

Timely decision-making between tricuspid repair and replacement can preserve right ventricular function and improve quality of life. Patients and families are encouraged to discuss individual risk factors and surgical options with their cardiac surgeon.

---

Ready to explore your second opinion options? Book your complimentary call to get personalized guidance today.

Read more posts